Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BERAPROST for Peripheral arterial occlusive disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BERAPROST was used for Peripheral arterial occlusive disease.

Most Reported Side Effects for BERAPROST

Side Effect Reports % Deaths Hosp.
Headache 34 14.6% 5 30
Dyspnoea 33 14.2% 5 30
Pulmonary hypertension 30 12.9% 8 23
Off label use 28 12.0% 5 20
Nausea 20 8.6% 6 16
Cardiac failure 17 7.3% 6 13
Condition aggravated 17 7.3% 3 12
Diarrhoea 17 7.3% 4 15
Right ventricular failure 17 7.3% 7 14
Anaemia 15 6.4% 2 12
Dizziness 15 6.4% 1 11
Syncope 15 6.4% 3 13
Pulmonary arterial hypertension 14 6.0% 7 10
Acute kidney injury 13 5.6% 3 12
Hypotension 13 5.6% 3 8

Other Indications for BERAPROST

Pulmonary arterial hypertension (115) Product used for unknown indication (36) Pulmonary hypertension (25) Systemic scleroderma (5)

Other Drugs Used for Peripheral arterial occlusive disease

RIVAROXABAN (761) CLOPIDOGREL BISULFATE (700) ASPIRIN (657) CILOSTAZOL (94) TICAGRELOR (89) ASPIRIN DL-LYSINE (72) EVOLOCUMAB (58) APIXABAN (55) ATORVASTATIN (55) UNSPECIFIED INGREDIENT (50)

Related Pages

BERAPROST Full Profile All Peripheral arterial occlusive disease Drugs BERAPROST Demographics BERAPROST Timeline